1Henter JI, Home A, Aric6 M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocy- tosis. Pediatr Blood Cancer,2007,48(2) : 124-131.
4Han AiR, Lee HR, Park BB, et al. Lymphoma-associated he- mophagocytic syndrome: clinical features and treatment out- come. Ann Hematol,2007,86(7) :493-498.
2Han AR,Lee HR,Park BB, et al. Lymphoma-associated hemophagocytic syndrome:clinical features and treatment outcome. Ann Hematol, 2007 ; 86 : 493 - 498.
3Henter JI, Home A, Arico M, et al. HLH-2004: Diagnostic and Therapeutic Guidelines for Hemophagocytic Lymphohistioeytosis. Pediatr Blood Cancer, 2007 ; 48 : 124 - 131.
4Bielekova B, Catalfamo M, Reichert-Scrivner S, et al. Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy ( daclizumab ) in multiple sclerosis. Proc Natl Acad Sci USA, 2006; 103:5941 -5946.
5Kontopoulou T, Tsaousis G, Vaidakis E, et al. Hemophagocytic syndrome in association with visceral leishmaniasis. Am J Med, 2002; 113 : 439 - 440.
6Gupta A, Tyrrell P, Valani R, et al. The role of the initial bone marrow aspirate in the diagnosis of hemophagocytic lymphobistiocytosis. Pediatr Blood Cancer, 2008; 51:402-404.
7Henter JI, Home A, Aric6 M, et al. HLH-200d- : Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer, 2007, 48 : 124-131.
8Risma K, Jordan MB. Hemophagocytic lymphohistiocytosis: apdates and evolving concepts. Curr Opin Pediatr, 2012, 24 : 9- 15.
9Larroche C, Moutbon L. Pathogenesis of hemophagocytic syndrome (HPS). Autoimmun Rev, 2004, 3: 69-75.
10Shin BC, Kim SW, Ha SW, et al. Hemophagocytic syndrome associated with bilateral adrenal gland tuberculosis. Korean J Intern Med, 2004, 19: 70-73.
2Henter JI, Home A, Aric6 M, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis[J]. Pediatr Blood Cancer,2007,48:124-131.
